Cargando…
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction
The mechanisms explaining progression to severe COVID-19 remain poorly understood. It has been proposed that immune system dysregulation/over-stimulation may be implicated, but it is not clear how such processes would lead to respiratory failure. We performed comprehensive multiparameter immune moni...
Autores principales: | Rouhani, Sherin J, Trujillo, Jonathan A, Pyzer, Athalia R, Yu, Jovian, Fessler, Jessica, Cabanov, Alexandra, Higgs, Emily F, Cron, Kyle R., Zha, Yuanyuan, Lu, Yihao, Bloodworth, Jeffrey C., Abasiyanik, Mustafa Fatih, Okrah, Susan, Flood, Blake A, Hatogai, Ken, Leung, Michael YK, Pezeshk, Apameh, Kozloff, Lara, Reschke, Robin, Strohbehn, Garth W., Chervin, Carolina Soto, Kumar, Madan, Schrantz, Stephen, Madariaga, Maria Lucia, Beavis, Kathleen G, Yeo, Kiang-Teck J., Sweis, Randy F., Segal, Jeremy, Tay, Savaş, Izumchenko, Evgeny, Mueller, Jeffrey, Chen, Lin S, Gajewski, Thomas F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629200/ https://www.ncbi.nlm.nih.gov/pubmed/34845442 http://dx.doi.org/10.21203/rs.3.rs-1083825/v1 |
Ejemplares similares
-
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
por: Rouhani, Sherin Juliet, et al.
Publicado: (2022) -
The Impact of Diabetes and African American Race in COVID-19 Severity
por: Arosemena, Marilyn A, et al.
Publicado: (2021) -
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
por: Briquez, Priscilla S., et al.
Publicado: (2021) -
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
por: Briquez, Priscilla S., et al.
Publicado: (2022) -
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
por: Reschke, Robin, et al.
Publicado: (2021)